[Nature] Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial |
10
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
10
The Indian street dog crisis and multispecies coexistence in tropical urban futures
10
A solid future for battery development
10
Excitation-inhibition imbalance underlies perioperative neurocognitive disorders: a single-nucleus transcriptomic perspective in mice hippocampus
10
Transfer learning with deployment-covariate recalibration for survival prediction under covariate shift
